Ventyx Biosciences, Inc. (VTYX) Misses Q4 EPS by 3c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q4 EPS of ($0.62), $0.03 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Citi expects Micron stock to rally into this event